Search results
Results from the WOW.Com Content Network
Financials as of September 30, 2023. [update] [1] Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2]
Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen. Early life. Collis was born in South Africa and attended the University of Witwatersrand, where he earned a Bachelor of Commerce. Collis is Jewish. Career
May 24, 2024 at 3:01 PM. (Reuters) -U.S. drug distributor Cencora has notified affected individuals that their personal and highly sensitive medical information was stolen during a cyberattack and ...
This page was last edited on 31 August 2023, at 09:27 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may ...
AmerisourceBergen now expects 2023 adjusted earnings in the range of $11.85 to $11.95 per share, compared with its prior forecast of $11.70 to $11.90 per share.
For premium support please call: 800-290-4726 more ways to reach us
PharMerica. PharMerica is a Fortune 1000 company formed in January 2007 from the merger of Kindred Healthcare 's pharmacy business with a subsidiary of AmerisourceBergen. [1] The company is headquartered in Louisville, Kentucky, and operates a major customer support center in Tampa, Florida. [2]
AmerisourceBergen (ABC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.